Multicenter ambispective observational study (prospective/retrospective)
Ovarian carcinoma
Cervical carcinoma
Endometrial carcinoma
Vulvar carcinoma
Patients younger than 18 years of age
Patients with early-stage gynecologic cancers not eligible for onco-vascular surgery
Patients undergoing vascular resection due to accidental injury of blood vessels not directly related to tumor infiltration.
Patients who have previously undergone vascular surgery for reasons unrelated to the study, to avoid data overlap.
The target population of the study consists of patients with advanced or recurrent gynecologic cancers involving major blood vessels by continuity or contiguity, who undergo en bloc tumor resection with simultaneous vascular resection and reconstruction during surgery for disease management.
Cohort
Other
Not listed
Overall Survival (OS)
Overall Survival (OS) at 5 years post-surgery, defined as the time from the surgical intervention to death from any cause. For patients who are still alive, OS will be censored at the date of the last follow-up.
Progression-Free Survival (PFS)
Progression-Free Survival (PFS) at 5 years post-surgery Defined as the time from surgery to the first detection of recurrence or death, whichever occurs first. For patients without events, PFS will be censored at the date of the last follow-u
Frequency of early postoperative complications
Complications will be classified according to the Clavien-Dindo system
Frequency of late postoperative complications
Complications will be classified according to the Clavien-Dindo system.
Quality of Life assessment using the EORTC QLQ-C30 questionnaire
Questionnaire administration
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
